Volume 19 Issue 7
Jul.  2021
Turn off MathJax
Article Contents
YU Da-jun. Review of transanal total mesorectal excision in the treatment of rectal cancer[J]. Chinese Journal of General Practice, 2021, 19(7): 1196-1198, 1205. doi: 10.16766/j.cnki.issn.1674-4152.002019
Citation: YU Da-jun. Review of transanal total mesorectal excision in the treatment of rectal cancer[J]. Chinese Journal of General Practice, 2021, 19(7): 1196-1198, 1205. doi: 10.16766/j.cnki.issn.1674-4152.002019

Review of transanal total mesorectal excision in the treatment of rectal cancer

doi: 10.16766/j.cnki.issn.1674-4152.002019
Funds:

 KJ2019A0387

  • Received Date: 2020-10-11
    Available Online: 2022-02-16
  • For a long time, colorectal surgeons have been continuously exploring the treatment of rectal cancer and improving the quality of life of patients and the therapeutic effect of rectal cancer. Low and median rectal cancer is common in Chinese patients. The current surgical operations used in the treatment of low and median rectal cancer include transanal total mesorectal excision (TaTME), ISR, Miles, APR, Hartmann, Parks, ELAPE and Dixon. Different surgical procedures are used in rectal cancer with different symptoms. For low rectal cancer patients with "difficult pelvis" such as huge tumor, mesangial hypertrophy and pelvic stenosis, TaTME can accurately locate the margin of the lesion, internal sphincter space in the anal canal and middle and low rectal membrane space. It can effectively reduce the risk of surgical complications, control the recurrence rate and improve the survival rate, which has been favoured and recognised by colorectal surgeons. However, TaTME requires doctors to have sufficient experience in laparoscopic and transanal surgery and is limited by the current development of laparoscopic equipment and instruments. In this paper, the developmental origin, application, advantages and disadvantages of TaTME and its future prospects are reviewed to provide some theoretical basis and empirical evidence for this research and practice.

     

  • loading
  • [1]
    娄彦昂, 高飞, 赵浩永, 等. 示踪剂技术在腹腔镜直肠癌根治术中应用的价值[J]. 医药论坛杂志, 2019, 40(10): 31-33. https://www.cnki.com.cn/Article/CJFDTOTAL-HYYX201910009.htm
    [2]
    李兵, 蒋泰君, 黄振国, 等. 超低位直肠癌完全经肛全直肠系膜切除术联合括约肌间切除术术后医院内感染的临床特点及影响因素分析[J]. 癌症进展, 2019, 17(17): 2048-2051. https://www.cnki.com.cn/Article/CJFDTOTAL-AZJZ201917017.htm
    [3]
    范海军, 田大广, 魏晓平, 等. 多学科团队对直肠癌同时性肝转移1例的诊治实践[J]. 中国临床研究, 2020, 33(4): 542-546. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGCK202004029.htm
    [4]
    陈弦, 李杰. 中医综合治疗干预Ⅲ-Ⅳ期结直肠癌的临床研究[J]. 中国中医基础医学杂志, 2017, 23(3): 371-374, 383. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYJC201703031.htm
    [5]
    应可明, 燕归如, 孙民昌, 等. 腹腔镜与开腹直肠癌全直肠系膜切除术的安全性及远期临床疗效评估[J]. 中国医药, 2019, 14(7): 1046-1050. doi: 10.3760/j.issn.1673-4777.2019.07.022
    [6]
    吴海俊, 李辉华, 胡水根, 等. 腹腔镜手术与开腹手术治疗结直肠癌的临床效果比较[J]. 中国基层医药, 2020, 27(14): 1689-1692. doi: 10.3760/cma.j.issn.1008-6706.2020.14.006
    [7]
    李鑫, 骆成玉, 李海连, 等. 腹腔镜辅助结直肠癌根治术的临床研究[J]. 北京医学, 2017, 39(7): 701-703. https://www.cnki.com.cn/Article/CJFDTOTAL-BJYX201707019.htm
    [8]
    汪明庆, 熊茂明, 陈博, 等. 腹腔镜与传统开放Dixon术治疗直肠癌的临床对照研究[J]. 中华全科医学, 2019, 17(1): 10-13. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201901004.htm
    [9]
    魏志平, 应荣彪, 姚俊, 等. 经肛门微创手术治疗直肠肿瘤疗效分析[J]. 中国基层医药, 2017, 24(12): 1782-1785. doi: 10.3760/cma.j.issn.1008-6706.2017.12.007
    [10]
    杨永江, 彭涛, 黄迪, 等. 内镜切割吻合器在直肠肿瘤经肛门切除术中的应用[J]. 中国临床研究, 2018, 31(4): 524-526, 530. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGCK201804023.htm
    [11]
    徐胜, 黄顺荣. 直肠癌经肛全直肠系膜切除术的临床研究现状[J]. 中国临床新医学, 2019, 12(8): 918-922. doi: 10.3969/j.issn.1674-3806.2019.08.27
    [12]
    BONJER H J, DEIJEN C L, ABIS G A, et al. Randomized trial of laparoscopic versus open surgery for rectal cancer[J]. New Eng J of Med, 2015, 372(14): 1324-1332. doi: 10.1056/NEJMoa1414882
    [13]
    WEXNER S D, BERHO M. Transanal total mesorectal excision of rectal carcinoma: Evidence to learn and adopt the technique[J]. Ann Surg, 2015, 261(2): 234-236. doi: 10.1097/SLA.0000000000000886
    [14]
    DEIJEN C L, VEITHUIS S, TSAI A, et al. COLOR III: A multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer[J]. Surg Endosc, 2016, 30(8): 3210-3215. doi: 10.1007/s00464-015-4615-x
    [15]
    孙瑞彩, 史学文. 经肛门全直肠系膜切除术的研究进展[J]. 中国肛肠病杂志, 2019, 39(2): 71-73. doi: 10.3969/j.issn.1000-1174.2019.02.033
    [16]
    WHIYEFORD M H, DENK P M, SWANSTRÖM L L. Feasibility of radical sigmoid colectomy performed as natural orifice transluminal endoscopic surgery (NOTES) using transanal endoscopic microsurgery[J]. Surg Endosc, 2007, 21(10): 1870-1874. doi: 10.1007/s00464-007-9552-x
    [17]
    TELEM D A, HAN K S, KIM M C, et al. Transanal rectosigmoid resection via natural orifice translumenal endoscopic surgery (NOTES) with total mesorectal excision in a large human cadaver series[J]. Surg Endosc, 2013, 27(1): 74-80. doi: 10.1007/s00464-012-2409-y
    [18]
    SYLLA P, RATTNER D W, DEIGADO S, et al. NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and laparoscopic assistance[J]. Surg Endosc, 2010, 24(5): 1205-1210. doi: 10.1007/s00464-010-0965-6
    [19]
    张忠涛, 姚宏伟. 再谈经肛全直肠系膜切除的进展、争议及前景[J]. 中国实用外科杂志, 2018, 38(1): 65-67. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWK201801018.htm
    [20]
    中华医学会外科学分会, 结直肠外科学组, 中华医学会外科学分会腹腔镜与内镜外科学组. 直肠癌经肛全直肠系膜切除专家共识及手术操作指南(2017版)[J]. 中国实用外科杂志, 2017, 37(9): 978-984. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWK201709012.htm
    [21]
    姚宏伟, 张忠涛, 郑民华. 直肠癌经肛全直肠系膜切除中国专家共识及临床实践指南(2019版)[J]. 中国实用外科杂志, 2019, 39(11): 1121-1128. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWK201911001.htm
    [22]
    陈谢平, 余启熠, 古柳根. 腹腔镜辅助TaTME治疗中低位直肠癌的效果观察[J]. 临床医药文献电子杂志, 2019, 6(91): 24-25. https://www.cnki.com.cn/Article/CJFDTOTAL-LCWX201991018.htm
    [23]
    池畔, 陈致奋. 机器人与腹腔镜全直肠系膜切除术的比较[J]. 中华胃肠外科杂志, 2017, 20(6): 610-613. doi: 10.3760/cma.j.issn.1671-0274.2017.06.003
    [24]
    康亮. 开展经肛全直肠系膜切除术的条件和经验[J]. 中华胃肠外科杂志, 2017, 20(6): 643. doi: 10.3760/j.issn.1671-0274.2017.06.015
    [25]
    KANG L, CHEN W H, LUO S L, et al. Transanal total mesorectal excision for rectal cancer: A preliminary report[J]. Surg Endosc, 2016, 30(6): 2552-2562. doi: 10.1007/s00464-015-4521-2
    [26]
    尤一舟, 史良会. 经肛门全直肠系膜切除术的发展现状[J]. 沈阳医学院学报, 2018, 20(2): 170-173. https://www.cnki.com.cn/Article/CJFDTOTAL-SYYX201802023.htm
    [27]
    何流, 肖毅. 经肛门全直肠系膜切除术在直肠癌根治中的应用[J]. 中华胃肠外科杂志, 2017, 20(8): 957-960. doi: 10.3760/cma.j.issn.1671-0274.2017.08.034
    [28]
    ATAIIAH S. Transanal minimally invasive surgery for total mesorectal excision[J]. Minim Invasive Ther Allied Technol, 2014, 23(1): 10-16. doi: 10.3109/13645706.2013.833118
    [29]
    LACY A M, TASENDE M M, DEIGADO S, et al. Transanal total mesorectal excision for rectal cancer: Outcomes after 140 patients[J]. J Am Coll Surg, 2015, 221(2): 415-423. doi: 10.1016/j.jamcollsurg.2015.03.046
    [30]
    SIMILLIS C, HOMPES R, PENNA M, et al. A systematic review of transanal total mesorectal excision: Is this the future of rectal cancer surgery?[J]. Colorectal Dis, 2016, 18(1): 19-36. doi: 10.1111/codi.13151
    [31]
    磨鹏诗, 杨平, 陈应驹. 腹腔镜辅助TaTME术在低位直肠癌患者中的临床效果及安全性研究[J]. 中华普外科手术学杂志(电子版), 2019, 13(2): 155-158. doi: 10.3877/cma.j.issn.1674-3946.2019.02.015
    [32]
    罗双灵, 康亮. 经肛腔镜手术/经肛TME的国际进展和质量数据[J]. 中国医刊, 2019, 54(1): 1-4. doi: 10.3969/j.issn.1008-1070.2019.01.001
    [33]
    王世磊, 胡艳瑞. 腹腔镜辅助经腹直肠前切除术治疗高龄低位直肠癌患者的效果观察[J]. 医药论坛杂志, 2019, 40(7): 128-130. https://www.cnki.com.cn/Article/CJFDTOTAL-HYYX201907045.htm
    [34]
    PENNA M, HOMPES R, ARNOLd S, et al. Incidence and risk factors for anastomotic failure in 1594 patients treated by transanal total mesorectal excision results from the international TaTME registry[J]. Ann Surg, 2019, 269(4): 700-711. doi: 10.1097/SLA.0000000000002653
    [35]
    胡金. 直肠癌经肛全直肠系膜切除术的临床研究现状[J]. 中外医学研究, 2020, 18(19): 182-184. https://www.cnki.com.cn/Article/CJFDTOTAL-YJZY202019078.htm
    [36]
    何风国, 师新荣. 腹腔镜直肠癌保肛手术后吻合口瘘的危险因素与对策研究[J]. 中国全科医学, 2019, 22(S2): 123-125. https://www.cnki.com.cn/Article/CJFDTOTAL-QKYX2019S2044.htm
    [37]
    EMILE S H, LACY F B D, KELLER D S, et al. Evolution of transanal total mesorectal excision for rectal cancer: From top to bottom[J]. World J Gastroint Surg, 2018, 10(3): 28-39. doi: 10.4240/wjgs.v10.i3.28
    [38]
    张纯博, 张超, 白军伟, 等. 经自然腔道取标本腹腔镜下直肠癌根治术与传统腹腔镜直肠癌根治术的回顾性对比研究[J]. 医药论坛杂志, 2020, 41(7): 10-14. https://www.cnki.com.cn/Article/CJFDTOTAL-HYYX202007003.htm
    [39]
    尹鹏, 乔磊, 徐华晓, 等. 快速康复外科理念在腹腔镜结直肠癌经自然腔道标本取出手术中的应用[J]. 中国医药, 2018, 13(6): 891-895. doi: 10.3760/j.issn.1673-4777.2018.06.023
    [40]
    CARMICHAEL H, D'ANDREA A P, SKANCKE M, et al. Feasibility of transanal total mesorectal excision (taTME) using the Medrobotics Flex System[J]. Surg Endo, 2019, 34(1): 485-491. http://www.cascade-fp7.eu/cras2013/proceedings/cras2013_Zenati.pdf
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(1)

    Article Metrics

    Article views (142) PDF downloads(7) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return